Diabetes and obesity are co-morbidity factors that increase the risk of AD and this study bring about a valid argument about the role of these pathological conditions on augmented brain PKR activation and consequent abnormal signaling. Here, EIF2AK2 is linked to obesity due to melanocortin 4 receptor deficiency.